Stocks TradingCharts.com

stocks prices, charts & quotes

Free Stock Prices, Charts & Stock Price Quotes

Search
Symbol Search Browse Symbols My Charts Menu
QUICK QUOTE
QUICK CHART
F.A.Questions Suggestion Box Advertising Info Commodity Charts Forex Markets

Stocks & Financial News

Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts

Colgate Announces 1st Quarter 2024 Results

NEW YORK, April 26, 2024 (BUSINESS WIRE) --
Colgate-Palmolive Company (NYSE:CL):

Net sales increased 6.2%; Organic sales* increased 9.8% GAAP EPS increased 84% to $0.83; Base Business EPS* increased 18% to $0.86 GAAP Gross profit margin and Base Business Gross profit margin* increased 310 basis points to 60.0% Net cash provided by operations was $681 million for the first three months of 2024 Colgate's leadership in toothpaste continued with its global market share at 41.3% year to date Colgate's leadership in manual toothbrushes continued with its global market share at 31.7% year to date The Company updated its financial guidance for full year 2024

First Quarter Total Company Results (GAAP)
----------------------------------------------------------------------------------------------------
($ in millions except per share amounts)         2024                 2023                Change
---------------------------------------- -------------------- -------------------- --------------------
Net Sales                                       $5,065               $4,770                       +6.2%
---------------------------------------- -------------------- -------------------- --------------------
EPS (diluted)                                    $0.83                $0.45                        +84%
---------------------------------------- -------------------- -------------------- --------------------
                           
                           
---------------------------------------- -------------------- -------------------- --------------------
First Quarter Total Company Results (Base Business - Non-GAAP)*
----------------------------------------------------------------------------------------------------
                              2024                 2023                Change
---------------------------------------- -------------------- -------------------- --------------------
Organic Sales Growth                                                                              +9.8%
--------------------------------------------------------------------------------   --------------------
*Indicates a non-GAAP financial measure. Please refer to "Non-GAAP Financial Measures" later in this release for definitions of non-GAAP financial measures and to "Table 5 - Geographic Sales Analysis Percentage Changes" and "Table 6 - Non-GAAP Reconciliations" included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Colgate-Palmolive Company (NYSE:CL) today reported results for first quarter 2024. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business first quarter results, "We are very pleased to have started 2024 with another quarter of strong top and bottom line performance as we continued to execute our strategy successfully. Net sales increased 6.2% and organic sales grew 9.8%, with organic sales growth in every division and across all categories. We are particularly pleased to have delivered double-digit growth in operating profit, net income and earnings per share for the third consecutive quarter while still investing for the long-term health of our business.

"The strong gross and operating margin expansion in the quarter funded a 16% increase in advertising and we expect strong levels of brand investment over the balance of 2024. We also continued to invest behind building and scaling the capabilities needed to drive our growth going forward, in areas like innovation, digital, data and analytics, revenue growth management and marketing effectiveness.

"Our strong growth momentum and great start to the year add to our confidence that we are executing the right strategies to deliver on our updated 2024 financial targets and generate consistent, compounded earnings per share growth."

Full Year 2024 Guidance

Based on current spot rates:

The Company is raising its net sales growth guidance to 2% to 5% (versus 1% to 4% previously) including a mid-single-digit negative impact from foreign exchange (versus low-single-digit negative impact previously). The Company is raising its organic sales growth guidance to 5% to 7% (versus 3% to 5% previously). On a GAAP basis, the Company still expects gross profit margin expansion, increased advertising investment and double-digit earnings-per-share growth. On a non-GAAP (Base Business) basis, the Company still expects gross profit margin expansion, increased advertising investment and mid to high-single-digit earnings-per-share growth.

Divisional Performance

See attached "Table 5 - Geographic Sales Analysis Percentage Changes" and "Table 4 - Segment Information" for additional information on net sales and operating profit by division.

First Quarter Sales Growth By Division                                                                        
(% change 1Q 2024 vs. 1Q 2023 except % of Total Company Sales)
----------------------------------------------------------------------------------------------------     -------------------- -------------------- --------------------
       % of Total               Net                Organic                As                 Organic              Pricing                FX
                            Company               Sales               Sales*              Reported              Volume
                             Sales                                                         Volume
-------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
North America                 20%                 +4.0%                +4.0%                +2.9%                +2.9%                +1.2%           --%
-------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
Latin America                 25%                +16.5%               +25.9%                +6.2%                +6.2%               +19.7%                -9.4%
-------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
Europe                        14%                 +9.5%                +7.2%                +3.1%                +3.1%                +4.1%                +2.3%
-------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
Asia Pacific                  14%                 -1.5%                +1.5%                -2.9%                -2.9%                +4.4%                -3.0%
-------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
Africa/Eurasia                5%                  -4.5%               +16.2%                +3.9%                +3.9%               +12.2%               -20.7%
-------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
Hill's                        22%                 +3.9%                +4.2%                -3.9%                -3.9%                +8.2%                -0.3%
-------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
               
-------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
Note: Table may not sum due to rounding.
 
First Quarter Operating Profit By Division
($ in millions)
----------------------------------------------------------------------------------------------------------
               1Q 2024            % Change vs           % to Net          Change in basis
                                                       1Q 2023               Sales          points vs 1Q 2023
                                                                                             % to Net Sales
-------------------------- -------------------- -------------------- -------------------- --------------------
North America                      $222                  15%                 22.3%                +220
-------------------------- -------------------- -------------------- -------------------- --------------------
Latin America                      $405                  29%                 32.3%                +300
-------------------------- -------------------- -------------------- -------------------- --------------------
Europe                             $144                  24%                 20.3%                +250
-------------------------- -------------------- -------------------- -------------------- --------------------
Asia Pacific                       $207                  2%                  28.5%                +110
-------------------------- -------------------- -------------------- -------------------- --------------------
Africa/Eurasia                      $66                  -3%                 23.9%                 +30
-------------------------- -------------------- -------------------- -------------------- --------------------
Hill's                             $199                  9%                  18.0%                 +80
-------------------------- -------------------- -------------------- -------------------- --------------------
               
-------------------------- -------------------- -------------------- -------------------- --------------------
Total Company, As Reported        $1,047                 15%                 20.7%                +160
-------------------------- -------------------- -------------------- -------------------- --------------------
*Indicates a non-GAAP financial measure. Please refer to "Non-GAAP Financial Measures" later in this release for definitions of non-GAAP financial measures and to "Table 6 - Non-GAAP Reconciliations" included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Prepared Materials and Webcast Information

At approximately 7:00 a.m. ET today, Colgate will post its prepared materials (in PDF format) regarding first quarter results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.

At 8:30 a.m. ET today, Colgate will host a conference call regarding first quarter results. To access this call as a webcast, please go to Colgate's website at www.colgatepalmolive.com.

About Colgate-Palmolive

Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. The Company is recognized for its leadership and innovation in promoting sustainability and community wellbeing, including its achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children's oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.7 billion children and their families since 1991. For more information about Colgate's global business and how the Company is building a future to smile about, visit www.colgatepalmolive.com. CL-E

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This press release and the related webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management's current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, the impact of foreign exchange, the impact of the war in Ukraine, the impact of the Israel-Hamas war, cost-reduction plans (including the 2022 Global Productivity Initiative), tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company's views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company's business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company's filings with the SEC (including, but not limited to, the information set forth under the captions "Risk Factors" and "Cautionary Statement on Forward-Looking Statements" in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company's Investor Relations Department or on the Company's website at www.colgatepalmolive.com.

Non-GAAP Financial Measures

The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:

Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges related to an ERISA litigation matter, the 2022 Global Productivity Initiative and product recall costs. Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments. Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company's underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See "Geographic Sales Analysis Percentage Changes" for the three months ended March 31, 2024 versus 2023 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company's normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company's business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company's underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See "Non-GAAP Reconciliations" for the three months ended March 31, 2024 and 2023 included with this release for a reconciliation of these financial measures to the related GAAP measures.

The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

As management uses free cash flow before dividends to evaluate the Company's ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See "Condensed Consolidated Statements of Cash Flows" for the three months ended March 31, 2024 and 2023 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

(See attached tables for first quarter results.)

                                                                                                                  Table 1
                                                                                       Colgate-Palmolive Company
 
                                                                              Condensed Consolidated Statements of Income
 
                                                                          For the Three Months Ended March 31, 2024 and 2023
 
                                                                      (Dollars in Millions Except Per Share Amounts) (Unaudited)
 
                                                               2024                                               2023
                                                                               ----------------------------------------------                        ----------------------------------------------
                                                                          
Net sales                                                                      $  5,065                        $  4,770  
                                                                          
Cost of sales                                                  2,026        2,058  
                                                                          
Gross profit                                                   3,039        2,712  
                                                                          
Gross profit margin                                             60.0                    %       56.9                    %
                                                                          
Selling, general and administrative expenses                   1,916        1,758  
                                                                          
Other (income) expense, net                                       76           45  
                                                                          
Operating profit                                               1,047          909  
                                                                          
Operating profit margin                                         20.7                    %       19.1                    %
                                                                          
Non-service related postretirement costs                          22          294  
                                                                          
Interest (income) expense, net                                    58           54  
                                                                          
Income before income taxes                                       967          561  
                                                                          
Provision for income taxes                                       238          147  
                                                                          
Effective tax rate                                              24.6                    %       26.2                    %
                                                                          
Net income including noncontrolling interests                    729          414  
                                                                          
Less: Net income attributable to noncontrolling interests         46           42  
                                                                          
Net income attributable to Colgate-Palmolive Company                           $    683                        $    372  
                                                                          
Earnings per common share                                                                    
Basic                                                                          $   0.83                        $   0.45  
Diluted                                                                        $   0.83                        $   0.45  
                                                                          
Supplemental Income Statement Information                                                    
Average common shares outstanding                                                            
Basic                                                          822.8        831.4  
Diluted                                                        825.9        833.0  
                                                                          
                                                                                                                                                                        Table 2
                                                                                                                                     Colgate-Palmolive Company
 
                                                                                                                               Condensed Consolidated Balance Sheets
 
                                                                                                                    As of March 31, 2024, December 31, 2023 and March 31, 2023
 
                                                                                                                                 (Dollars in Millions) (Unaudited)
                                                                                                                                
                                                                                   March 31,                                        December 31,                                         March 31,
                                                                                     2024                                               2023                                               2023
                                                                                                     ----------------------------------------------                        ----------------------------------------------                        ----------------------------------------------
Cash and cash equivalents                                                                            $  1,079                        $    966                        $    867  
Receivables, net                                                                     1,813        1,586        1,590  
Inventories                                                                          1,914        1,934        2,110  
Other current assets                                                                   834          793          899  
Property, plant and equipment, net                                                   4,497        4,582        4,363  
Goodwill                                                                             3,341        3,410        3,375  
Other intangible assets, net                                                         1,837        1,887        1,918  
Other assets                                                                         1,256        1,235        1,051  
                                                                                                     -------------------- ------ --------------------                      -------------------- ------ --------------------                      -------------------- ------ --------------------
                                                                                                     $ 16,571                        $ 16,393                        $ 16,173  
   Total assets
                                                                                                     ==================== ====== ====================                      ==================== ====== ====================                      ==================== ====== ====================
                                                                                                                                
Total debt                                                                                           $  8,689                        $  8,549                        $  8,907  
Other current liabilities                                                            4,776        4,411        4,404  
Other non-current liabilities                                                        2,489        2,476        2,437  
                                                                                                     -------------------- ------ --------------------                      -------------------- ------ --------------------                      -------------------- ------ --------------------
                                                                                    15,954       15,436       15,748  
   Total liabilities
Total Colgate-Palmolive Company shareholders' equity        230          609           (6                    )
Noncontrolling interests                                                               387          348          431  
                                                                                                     -------------------- ------ --------------------                      -------------------- ------ --------------------                      -------------------- ------ --------------------
                                                                                                     $ 16,571                        $ 16,393                        $ 16,173  
   Total liabilities and equity
                                                                                                     ==================== ====== ====================                      ==================== ====== ====================                      ==================== ====== ====================
                                                                                                                                
Supplemental Balance Sheet Information                                                                                                             
Debt less cash, cash equivalents and marketable securities(1)                                        $  7,379                        $  7,404                        $  7,764  
Note:
                                                                                                                                                                             Table 3
                                                                                                                    Colgate-Palmolive Company
 
                                                                                                         Condensed Consolidated Statements of Cash Flows
 
                                                                                                       For the Three Months Ended March 31, 2024 and 2023
 
                                                                                                                (Dollars in Millions) (Unaudited)
                                                                                                                                     
                                                                                                                      2024                                                   2023
                                                                                                                                  ------------------------------------------------------                        ----------------------------------------------
Operating Activities                                                                                                                                    
                                                                                                                                  $            729                        $    414  
  Net income including noncontrolling interests
                                                                                                                
  Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations:
                                                                                                                            150          128  
     Depreciation and amortization
                                                                                                                 --          267  
     ERISA litigation matter
                                                                                                                             30           (7                    )
     Restructuring and termination benefits, net of cash
                                                                                                                             19           14  
     Stock-based compensation expense
                                                                                                                             12          (20                    )
     Deferred income taxes
                                                                                                                                                        
     Cash effects of changes in:
                                                                                                                           (252                    )        (57                    )
        Receivables
                                                                                                                             11          (24                    )
        Inventories
                                                                                                                              8           (2                    )
        Accounts payable and other accruals
                                                                                                                            (26                    )         22  
        Other non-current assets and liabilities
                                                                                                                                  -------------------- -------------- --------------------                      -------------------- ------ --------------------
                                                                                                                            681          735  
           Net cash provided by (used in) operations
                                                                                                                                     
Investing Activities                                                                                                                                    
                                                                                                                           (126                    )       (163                    )
  Capital expenditures
                                                                                                                           (139                    )       (112                    )
  Purchases of marketable securities and investments
                                                                                                                             78           14  
  Proceeds from sale of marketable securities and investments
                                                                                                                             (6                    )         (3                    )
  Other investing activities
                                                                                                                                  -------------------- -------------- --------------------                      -------------------- ------ --------------------
                                                                                                                           (193                    )       (264                    )
           Net cash provided by (used in) investing activities
                                                                                                                                     
Financing Activities                                                                                                                                    
                                                                                                                            728         (927                    )
  Short-term borrowing (repayment) less than 90 days, net
                                                                                                                           (500                    )       (500                    )
  Principal payments on debt
                                                                                                                              1        1,495  
  Proceeds from issuance of debt
                                                                                                                           (394                    )       (390                    )
  Dividends paid
                                                                                                                           (509                    )       (180                    )
  Purchases of treasury shares
                                                                                                                            336          122  
  Proceeds from exercise of stock options
                                                                                                                            (23                    )          5  
  Other financing activities
                                                                                                                                  -------------------- -------------- --------------------                      -------------------- ------ --------------------
                                                                                                                           (361                    )       (375                    )
           Net cash provided by (used in) financing activities
                                                                                                                                     
Effect of exchange rate changes on Cash and cash equivalents                                                                (14                    )         (4                    )
                                                                                                                                  -------------------- -------------- --------------------                      -------------------- ------ --------------------
Net increase (decrease) in Cash and cash equivalents                                                                        113           92  
Cash and cash equivalents at beginning of the period                                                                        966          775  
                                                                                                                                  -------------------- -------------- --------------------                      -------------------- ------ --------------------
Cash and cash equivalents at end of the period                                                                                    $          1,079                        $    867  
                                                                                                                                  ==================== ============== ====================                      ==================== ====== ====================
Supplemental Cash Flow Information                                                                                                                      
Free cash flow before dividends (Net cash provided by operations less Capital expenditures)                                                             
                                                                                                                                  $            681                        $    735  
  Net cash provided by operations
                                                                                                                           (126                    )       (163                    )
  Less: Capital expenditures
                                                                                                                                  -------------------- -------------- --------------------                      -------------------- ------ --------------------
Free cash flow before dividends                                                                                                   $            555                        $    572  
                                                                                                                                  ==================== ============== ====================                      ==================== ====== ====================
                                                                                                                                     
                                                                                                                                     
Income taxes paid                                                                                                                 $            150                        $    171  
                                                                                           Table 4
                                                                           Colgate-Palmolive Company
 
                                                                              Segment Information
 
                                                              For the Three Months Ended March 31, 2024 and 2023
 
                                                                       (Dollars in Millions) (Unaudited)
                   
                                                               Three Months Ended March 31,
                                        2024                                               2023
                                                        ----------------------------------------------                        ----------------------------------------------
Net Sales                                                             
Oral, Personal and Home Care                                          
                                                   
North America                                           $    997                        $    958  
Latin America                           1,253        1,075  
Europe                                    711          650  
Asia Pacific                              727          738  
Africa/Eurasia                            276          288  
                                                        -------------------- ------ --------------------                      -------------------- ------ --------------------
                                                   
Total Oral, Personal and Home Care      3,963        3,709  
                                                   
Pet Nutrition                           1,102        1,061  
                                                        -------------------- ------ --------------------                      -------------------- ------ --------------------
                                                   
Total Net Sales                                         $  5,065                        $  4,770  
                                                        ==================== ====== ====================                      ==================== ====== ====================
                                                   
                                                   
                                                               Three Months Ended March 31,
                                        2024                                               2023
                                                        ----------------------------------------------                        ----------------------------------------------
Operating Profit                                                      
Oral, Personal and Home Care                                          
                                                   
North America                                           $    222                        $    193  
Latin America                             405          315  
Europe                                    144          116  
Asia Pacific                              207          202  
Africa/Eurasia                             66           68  
                                                        -------------------- ------ --------------------                      -------------------- ------ --------------------
                                                   
Total Oral, Personal and Home Care      1,044          894  
                                                   
Pet Nutrition                             199          183  
Corporate(1)                             (196                    )       (168                    )
                                                        -------------------- ------ --------------------                      -------------------- ------ --------------------
                                                   
Note: Table may not sum due to rounding.
 
(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets.
 
Corporate Operating profit (loss) for the three months ended March 31, 2024 included charges resulting from the 2022 Global Productivity Initiative of $36.
 
                                                                                                                                                                                                                                     Table 5
                                                                                                                                   Colgate-Palmolive Company
 
                                                                                                                         Geographic Sales Analysis Percentage Changes
 
                                                                                                                      For the Three Months Ended March 31, 2024 vs. 2023
 
                                                                                                                                          (Unaudited)
                          
                          
                          
                                                                                     COMPONENTS OF SALES CHANGE
                                                                                                                                           ----------------------------------------------------------------------------------------------------------------------------------------
                                      
                                        Pricing          
                                        Coupons          
                         Sales                           Consumer &         
                        Change                 Organic              As Reported              Organic                 Trade                 Foreign
Region                                   As Reported           Sales Change              Volume                 Volume               Incentives              Exchange
---------------------------------                      -------------------                       -------------------                       -------------------                       -------------------                       -------------------                       -------------------
                                      
Total Company                              6.2 %                  9.8 %                  1.3 %                  1.3 %                  8.5 %                     (3.6 )%
                                      
North America                              4.0 %                  4.0 %                  2.9 %                  2.9 %                  1.2 %           -- %
                                      
Latin America                             16.5 %                 25.9 %                  6.2 %                  6.2 %                 19.7 %                     (9.4 )%
                                      
Europe                                     9.5 %                  7.2 %                  3.1 %                  3.1 %                  4.1 %                      2.3 %
                                      
Asia Pacific                              (1.5 )%                 1.5 %                 (2.9 )%                (2.9 )%                 4.4 %                     (3.0 )%
                                      
Africa/Eurasia                            (4.5 )%                16.2 %                  3.9 %                  3.9 %                 12.2 %                    (20.7 )%
                                      
Total CP Products                          6.8 %                 11.4 %                  2.8 %                  2.8 %                  8.6 %                     (4.5 )%
                                      
Hill's          3.9 %                  4.2 %                 (3.9 )%                (3.9 )%                 8.2 %                     (0.3 )%
                                      
                                      
Emerging Markets(1)                        7.5 %                 15.7 %                  2.2 %                  2.2 %                 13.5 %                     (8.1 )%
                                      
Note: Table may not sum due to rounding.
 
                                                                                                                                                                                                                                     Table 6
                                                                                                                        Colgate-Palmolive Company
 
                                                                                                                        Non-GAAP Reconciliations
 
                                                                                                           For the Three Months Ended March 31, 2024 and 2023
 
                                                                                                       (Dollars in Millions Except Per Share Amounts) (Unaudited)
                                                                                                                       
Selling, General and Administrative Expenses                    2024                 2023           
                                                                            -------------------- -------------- --------------------                      -------------------- -------------- --------------------
Selling, general and administrative expenses, GAAP                          $          1,916                        $          1,758      
2022 Global Productivity Initiative                                    (1                    )     --      
                                                                            -------------------- -------------- --------------------                      -------------------- -------------- --------------------
Selling, general and administrative expenses, non-GAAP                    $                    $          1,915                        $          1,758      
                                                       ==================== ==================== ============== ====================                      ==================== ============== ====================
                                                                                                                       
                                                                                                                       
Other (Income) Expense, Net                                     2024                 2023           
                                                                            -------------------- -------------- --------------------                      -------------------- -------------- --------------------
Other (income) expense, net, GAAP                                           $             76                        $             45      
2022 Global Productivity Initiative                                   (35                    )                 (5                    )    
Product recall costs                                       --                  (25                    )    
                                                                            -------------------- -------------- --------------------                      -------------------- -------------- --------------------
Other (income) expense, net, non-GAAP                                       $             41                        $             15      
                                                                            ==================== ============== ====================                      ==================== ============== ====================
                                                                                                                       
                                                                                                                       
Operating Profit                                                2024                 2023                      % Change
                                                                            -------------------- -------------- --------------------                      -------------------- -------------- --------------------                      ------------------------------
Operating profit, GAAP                                                      $          1,047                        $            909             15 %
2022 Global Productivity Initiative                                    36                    5      
Product recall costs                                       --                   25      
                                                                            -------------------- -------------- --------------------                      -------------------- -------------- --------------------                      ------------------------------
Operating profit, non-GAAP                                                  $          1,083                        $            939             15 %
                                                                            ==================== ============== ====================                      ==================== ============== ====================                      ========== ====================
                                                                                                                       
                                                                                                                                 Basis Point
Operating Profit Margin                                         2024                 2023                       Change
                                                                            -------------------- -------------- --------------------                      -------------------- -------------- --------------------                      ------------------------------
Operating profit margin, GAAP                                        20.7                    %               19.1                    %          160  
2022 Global Productivity Initiative                                   0.7                    %                0.1                    %    
Product recall costs                                       --                    %                0.5                    %    
                                                                            -------------------- -------------- --------------------                      -------------------- -------------- --------------------                      ------------------------------
Operating profit margin, non-GAAP                                    21.4                    %               19.7                    %          170  
                                                                            ==================== ============== ====================                      ==================== ============== ====================                      ========== ====================
 
                                                                                                                       
Non-Service Related Postretirement Costs                        2024                 2023           
                                                                            -------------------- -------------- --------------------                      -------------------- -------------- --------------------
Non-service related postretirement costs, GAAP                              $             22                        $            294      
ERISA litigation matter                                    --                 (267                    )    
2022 Global Productivity Initiative                        --                   (1                    )    
                                                                            -------------------- -------------- --------------------                      -------------------- -------------- --------------------
                                                                                                                                                                                                                                     Table 6
                                                                                                                                                                                                                                     Continued
                                                                                                                                                                                Colgate-Palmolive Company
 
                                                                                                                                                                                Non-GAAP Reconciliations
 
                                                                                                                                                                   For the Three Months Ended March 31, 2024 and 2023
 
                                                                                                                                                               (Dollars in Millions Except Per Share Amounts) (Unaudited)
 
                                 2024                                                                                                                                                                                                                                      2024
                                    -------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                        Income                  Income                      Provision                   Net Income                        Less: Income                       Net Income                 Effective                  Diluted
                                           Before                  Before                                            For                                          Including                                          Attributable to                                       Attributable                                    Income                                      Earnings
                                           Income                  Income                                          Income                                      Noncontrolling                                        Noncontrolling                                             To                                       Tax Rate(2)                                   Per Share
                                            Taxes                   Taxes                                         Taxes(1)                                        Interests                                             Interests                                            Colgate-
                                                                                                                                                                                                                                                                             Palmolive
                                                                                                                                                                                                                                                                              Company
                                    -------------------- -----------------------                         ------------------------                       ---------------------------                       ----------------------------------                       --------------------------                       -------------------                       ------------------------
As Reported GAAP                                       $                    $   967                      $  238                      $     729                      $             46                      $    683             24.6 %                          $ 0.83
2022 Global Productivity Initiative        36        6          30     --         30             (0.3 )%        0.03
                                    -------------------- ------------------   -----                      -------------------- ----                      -------------------- -------                      -------------------- --------------                      -------------------- ------                      -------------- -----                      -------------------- ----
Non-GAAP                                               $                    $ 1,003                      $  244                      $     759                      $             46                      $    713             24.3 %                          $ 0.86
                                    ==================== ==================   =====                      ==================== ====                      ==================== =======                      ==================== ==============                      ==================== ======                      ============== =====                      ==================== ====
 
 
                                 2023                                                                                                                                                                                                                                      2023
                                    -------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                        Income                  Income                      Provision                   Net Income                        Less: Income                       Net Income                 Effective                  Diluted
                                           Before                  Before                                            For                                          Including                                          Attributable to                                       Att

Do not sell my personal information

Copyright © 2024. All market data is provided by Barchart Solutions. Information is provided "as is" and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.